Autoimmune Blistering Diseases Study

Launched by UNIVERSITY OF PENNSYLVANIA · Apr 25, 2016

Keywords

ClinConnect Summary

The Autoimmune Blistering Diseases Study is a clinical trial focused on finding new treatments for serious skin conditions called pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid. These conditions are autoimmune diseases, meaning the body's immune system mistakenly attacks its own skin, leading to painful blisters. Researchers are looking for effective ways to measure how severe these diseases are, which will help them understand how well new treatments work.

This trial is currently recruiting participants who are 18 years or older and have been diagnosed with one of these conditions. Eligible participants should be able to provide informed consent, meaning they understand what the study involves. Unfortunately, individuals under 18, those without these specific skin diseases, and certain employees or students from the University of Pennsylvania cannot participate. If you join the study, you can expect to contribute to important research that may benefit others with these conditions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Gender/Age: Males or females above 18 years old
• • Diagnosis: pemphigus vulgaris, pemphigus foliaceus, bullous pemphigoid
• • Subjects able to give informed consent
• Exclusion Criteria:
• • Patients who are under age 18 years.
• • Patients without pemphigus or pemphigoid diseases
• • Penn employees
• • Penn students
• • Cognitively impaired persons